The Antibiotic Resistance Market is segmented by drug class, revealing a dynamic landscape where established players and emerging contenders vie for dominance. According to the MRFR analysis, Oxazolidinones currently hold the largest market share, prized for their potency against resistant Gram-positive pathogens. However, Lipoglycopeptides are identified as the...
Portuguese (Brazil) 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Tiếng Việt